Clinical trials: Oligometastatic Malignant Solid Neoplasm
Oligometastatic Malignant Solid Neoplasm
Total RadIoTherapy of Oligometastatic caNcerS
This is a Phase III non-blinded randomized study evaluating patients with oligometastatic cancers (up to 10 metastases). Subjects are randomized 1:1 to stereotactic ablative radiotherapy (SABR) plus standard of care therapies…
- Trial name
- TRITONS (NCT06587490)
- Testing
- stereotactic ablative radiotherapy
- Where
- United States
- Volunteers
- 300 people
- Sponsor
- University of California, San Diego
Oligometastatic Malignant Solid Neoplasm
Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor
This phase II trial studies how well systemic therapy with or without local consolidative therapy work in treating patients with solid tumor that has spread to 1 site of other places in the body.
- Trial name
- NCT03599765
- Testing
- Best Practice, Local Consolidation Therapy
- Where
- 12 sites in United States
- Volunteers
- 380 people
- Sponsor
- M.D. Anderson Cancer Center